Thermo Fisher Scientific Inc. $TMO Holdings Boosted by Temasek Holdings Private Ltd

Key Points

• Temasek Holdings Private Ltd increased its stake in Thermo Fisher Scientific by 19% during the first quarter, acquiring an additional 200,869 shares, bringing its total to 1,258,117 shares.
• Other hedge funds, such as GAMMA Investing LLC and Nuveen LLC, have significantly increased their holdings in Thermo Fisher, with GAMMA increasing its position by 60,610.9% this quarter.
• Thermo Fisher Scientific has a market capitalization of $185.86 billion and announced a quarterly dividend of $0.43 per share, representing a 0.3% yield.

Temasek Holdings Private Ltd grew its stake in Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 19.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,258,117 shares of the medical research company's stock after purchasing an additional 200,869 shares during the quarter. Thermo Fisher Scientific makes up 2.5% of Temasek Holdings Private Ltd's holdings, making the stock its 13th biggest position. Temasek Holdings Private Ltd owned about 0.33% of Thermo Fisher Scientific worth $626,039,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of TMO. Mondrian Investment Partners LTD increased its position in Thermo Fisher Scientific by 146.1% during the first quarter. Mondrian Investment Partners LTD now owns 214,506 shares of the medical research company's stock worth $106,738,000 after purchasing an additional 127,357 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Thermo Fisher Scientific by 22.0% during the 1st quarter. GAMMA Investing LLC now owns 4,862 shares of the medical research company's stock worth $2,419,000 after buying an additional 877 shares in the last quarter. Cetera Trust Company N.A grew its stake in shares of Thermo Fisher Scientific by 3.3% in the first quarter. Cetera Trust Company N.A now owns 4,646 shares of the medical research company's stock worth $2,312,000 after acquiring an additional 150 shares in the last quarter. Philip James Wealth Mangement LLC purchased a new stake in shares of Thermo Fisher Scientific during the first quarter worth $268,000. Finally, Security National Bank of SO Dak increased its holdings in Thermo Fisher Scientific by 0.8% during the 4th quarter. Security National Bank of SO Dak now owns 8,726 shares of the medical research company's stock worth $4,540,000 after purchasing an additional 73 shares during the period. 89.23% of the stock is currently owned by institutional investors and hedge funds.

Thermo Fisher Scientific Price Performance

Shares of NYSE TMO traded down $5.38 during trading on Wednesday, hitting $477.03. 1,442,085 shares of the company were exchanged, compared to its average volume of 2,409,042. The firm's fifty day moving average price is $463.59 and its 200 day moving average price is $452.20. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.93 and a quick ratio of 1.50. The company has a market cap of $180.13 billion, a price-to-earnings ratio of 27.59, a PEG ratio of 2.60 and a beta of 0.75. Thermo Fisher Scientific Inc. has a 1 year low of $385.46 and a 1 year high of $623.77.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, beating analysts' consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%.The business had revenue of $10.86 billion during the quarter, compared to analysts' expectations of $10.68 billion. During the same quarter last year, the business posted $5.37 earnings per share. The business's revenue for the quarter was up 2.9% on a year-over-year basis. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. On average, sell-side analysts expect that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Monday, September 15th will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's payout ratio is 9.95%.

Wall Street Analyst Weigh In

Several research analysts have commented on TMO shares. Wall Street Zen cut shares of Thermo Fisher Scientific from a "buy" rating to a "hold" rating in a report on Sunday. Evercore ISI dropped their target price on Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating on the stock in a report on Tuesday, July 8th. William Blair assumed coverage on Thermo Fisher Scientific in a report on Monday, August 18th. They set an "outperform" rating for the company. UBS Group raised their target price on Thermo Fisher Scientific from $460.00 to $500.00 and gave the stock a "neutral" rating in a research report on Thursday, July 24th. Finally, Raymond James Financial reaffirmed an "outperform" rating and issued a $535.00 price target (up from $525.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 24th. Sixteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $589.38.

Insider Activity at Thermo Fisher Scientific

In other Thermo Fisher Scientific news, CAO Joseph R. Holmes sold 385 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $492.63, for a total transaction of $189,662.55. Following the completion of the sale, the chief accounting officer owned 2,319 shares in the company, valued at $1,142,408.97. This trade represents a 14.24% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gianluca Pettiti sold 400 shares of the stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $479.98, for a total transaction of $191,992.00. Following the transaction, the executive vice president directly owned 22,367 shares in the company, valued at $10,735,712.66. The trade was a 1.76% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 30,066 shares of company stock worth $14,182,963. 0.33% of the stock is currently owned by corporate insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.